Page last updated: 2024-08-17

mepazine and biperiden

mepazine has been researched along with biperiden in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Betzel, C; Bockhorn, M; Buchholz, A; El Gammal, AT; Graß, JK; Grupp, K; Güngör, C; Hofmann, BT; Izbicki, JR; Kapis, S; Klemp, C; Konczalla, L; Landschulze, D; Lüddeke, J; Meier, C; Nuguid, T; Perez, DR; Püschel, K; Sauter, G; Schumacher, U; Spriestersbach, SL; Steinberg, P; Uzunoglu, FG; Wenzel, N; Wolski, A; Wolters-Eisfeld, G; Yao, D	1

Reviews

1 review(s) available for mepazine and biperiden

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for mepazine and biperiden

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer. International journal of cancer, 2020, 03-15, Volume: 146, Issue:6 Topics: Animals; Biperiden; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Humans; Mice; Mice, Knockout; Models, Molecular; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; NF-kappa B; Pancreatic Neoplasms; Phenothiazines; Proto-Oncogene Proteins c-rel; Random Allocation; Xenograft Model Antitumor Assays	2020

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011

Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.

International journal of cancer, 2020, 03-15, Volume: 146, Issue:6

Topics: Animals; Biperiden; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Humans; Mice; Mice, Knockout; Models, Molecular; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; NF-kappa B; Pancreatic Neoplasms; Phenothiazines; Proto-Oncogene Proteins c-rel; Random Allocation; Xenograft Model Antitumor Assays

2020